The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

V.H. Knaryan

Buniatian Institute of Biochemistry NAS RA

F.P. Sarukhanyan

Buniatian Institute of Biochemistry NAS RA

Ca2+-regulated enzymes calpain and calcineurin in neurodegenerative processes and prospects for neuroprotective pharmacotherapy

Authors:

V.H. Knaryan, F.P. Sarukhanyan

More about the authors

Views: 971

Downloaded: 2


To cite this article:

Knaryan VH, Sarukhanyan FP. Ca2+-regulated enzymes calpain and calcineurin in neurodegenerative processes and prospects for neuroprotective pharmacotherapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(7):32‑40. (In Russ.)
https://doi.org/10.17116/jnevro202312307132

Recommended articles:
Cere­brolysin in the treatment of cognitive impairment. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(3):20-25
Reha­bilitation’s possibility of the patients with severe Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(3):56-60
Analysis of GBA muta­tions in patients with Parkinson’s disease in the Krasnoyarsk region. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(4):103-108
Orthostatic hypo­tension in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(6):16-21
Modern achievements in the diagnosis and treatment of glaucoma. Russian Annals of Ophthalmology. 2023;(3):96-106
Abdo­minal pain in Parkinson’s disease. Russian Journal of Pain. 2023;(2):12-21

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation



We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.